Alumis Inc. (ALMS) key performance indicators and operating metrics (7 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Psoriasis Area and Severity Index 100 | 54.00 percent | FY2026-Q2 |
| Psoriasis Area and Severity Index 90 | 75.00 percent | FY2026-Q2 |
| Dermatology Life Quality Index 0 or 1 | 50.00 percent | FY2026-Q1 |
| Patients enrolled and randomized | 1.7K | FY2026-Q2 |
| Collaboration revenue | 1.7M | FY2026-Q2 |
| Single Reportable revenue | 1.66M | FY2026-Q2 |
| Total merger-related expenses | 6.3M | FY2025-Q3 |
Back to ALMS overview · ALMS earnings · ALMS holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.